L
Li Xiao
Researcher at Shaanxi Normal University
Publications - 19
Citations - 117
Li Xiao is an academic researcher from Shaanxi Normal University. The author has contributed to research in topics: Medicine & Motility. The author has an hindex of 4, co-authored 13 publications receiving 66 citations.
Papers
More filters
Journal ArticleDOI
Effects of miR-29a and miR-101a expression on myocardial interstitial collagen generation after aerobic exercise in myocardial-infarcted rats
Li Xiao,Huimin He,Lele Ma,Miaomiao Da,Sinan Cheng,Yan Duan,Qian Wang,Huayi Wu,Xigui Song,Wei Duan,Zhenjun Tian,Yingchun Hou +11 more
TL;DR: It is believed that controlled intermittent aerobic exercise is beneficial to the healing and discovery of damaged cardiac tissues and their function after MI and inhibit TGFβ pathway via up-regulation to the expression of microRNAs and miR-101a and finally cause a reduced fibrosis and scar formation in cardiac tissue.
Journal ArticleDOI
ANXA2 enhances the progression of hepatocellular carcinoma via remodeling the cell motility associated structures
Hongyan Shi,Li Xiao,Wei Duan,Huimin He,Lele Ma,Miaomiao Da,Yan Duan,Qian Wang,Huayi Wu,Xigui Song,Yingchun Hou +10 more
TL;DR: The results indicate that ANXA2 plays an important role to enhance the malignant behaviors of HCC cells, and the enhancement is closely based on its remodeling to cell structures.
Journal ArticleDOI
Development of a novel drug targeting delivery system for cervical cancer therapy
Li Xiao,Ma Ni,Huimin He,Jinmei Li,Sinan Cheng,Qian Yang,Yifan Hou,Fengying Song,Huijuan Jin,Xiaorong Su,Jing Dong,Ruiye Zuo,Xigui Song,Wei Duan,Yingchun Hou +14 more
TL;DR: A CSP3 conjugated liposome drug delivery system containing doxorubicin (DOX) and microRNA101 (miR101) expression plasmids (CSP3-Lipo-DOX-miR 101) showed that the system demonstrated significantly enhanced cytotoxicity to SiHa cells and DOX resistant Si Ha cells, SiHa/ADR.
Journal ArticleDOI
A novel targeted delivery system for drug-resistant hepatocellular carcinoma therapy
Li Xiao,Yang Hou,Huimin He,Sinan Cheng,Yifan Hou,Huijuan Jin,Xigui Song,Guochao Nie,Yingchun Hou +8 more
TL;DR: It is suggested that HCSP4-Lipo-DOX-miR101 may serve as a promising novel targeted delivery system for improving the therapeutic efficiency of drug-resistant hepatocellular carcinoma.
Journal ArticleDOI
Annexin A2 Enhances the Progression of Colorectal Cancer and Hepatocarcinoma via Cytoskeleton Structural Rearrangements.
Huimin He,Li Xiao,Sinan Cheng,Qian Yang,Jinmei Li,Yifan Hou,Fengying Song,Xiaorong Su,Huijuan Jin,Zheng Liu,Jing Dong,Ruiye Zuo,Xigui Song,Yanyan Wang,Kun Zhang,Wei Duan,Yingchun Hou +16 more
TL;DR: It is suggested that ANXA2 plays important roles in maintaining the malignancy of colorectal and hepatic cancer by enhancing the cell proliferation, motility, and development of the motility associated microstructures of cancer cells based on a possible complicated signal pathway.